Christopher D. Payne
0000-0003-0549-5455
Publication & Citation Trends
Publications
0 total
Pharmacokinetics, Safety, and Efficacy of Ixekizumab in Chinese Patients with Moderate-to-Severe Plaque Psoriasis: A Phase 1, Single- and Multiple-Dose Study.
Cited by 3
Semantic Scholar
Ixekizumab Citrate-Free Formulation: Results from Two Clinical Trials OA
Cited by 27
Semantic Scholar
Subcutaneous Injection Site Pain of Formulation Matrices
Cited by 27
Semantic Scholar
14066 Pharmacokinetics, safety and efficacy of ixekizumab in Chinese patients with plaque psoriasis: Results from a phase 1 single- and multiple-dose study
Cited by 0
Semantic Scholar
Pharmacokinetics, Safety, and Tolerability of Single‐ and Multiple‐Dose Once‐Daily Baricitinib in Healthy Chinese Subjects: A Randomized Placebo‐Controlled Study OA
Cited by 20
Semantic Scholar
THU0199 PHARMACOKINETICS, SAFETY AND TOLERABILITY OF SINGLE- AND MULTIPLE- DOSE ONCE-DAILY BARICITINIB IN CHINESE HEALTHY VOLUNTEERS – A RANDOMIZED PLACEBO-CONTROLLED STUDY OA
Cited by 1
Semantic Scholar
Disposition of [14C]LY2606368 following intravenous administration in patients with advanced and/or metastatic solid tumours
Cited by 1
Semantic Scholar
Prediction of Transporter‐Mediated Drug‐Drug Interactions for Baricitinib OA
Cited by 57
Semantic Scholar
Research Topics
Antiplatelet Therapy and Cardiovascular Diseases
(32)
Lipoproteins and Cardiovascular Health
(16)
Inflammatory mediators and NSAID effects
(10)
Atrial Fibrillation Management and Outcomes
(8)
Venous Thromboembolism Diagnosis and Management
(6)
Affiliations
Veterinary Medicines Directorate
Eli Lilly (United States)
Eli Lilly (United Kingdom)